Our research indicates that PAC and ABR may be potentially effective traditional Chinese medicines for the treatment of IBS, and the common active compounds of these two drugs, quercetin, berberine, and wogonin, may target proteins TP53, NT5E, JUN, and CD74, which have a positive causal relationship with IBS. Here, CD74 is linked to irritable bowel syndrome.